DTASelect v2.0.39
/home/mauraisa/sequest_data/Thompson_lab_samples/Ari/pad_auto/ms2/20190912_Thompson_PAD2_trypsin_t3
/home/mauraisa/dbase/Human_uniprot-reviewed_Weerapana_Lab_10202017_rev.fasta
SEQUEST 3.0 in SQT format.
 --trypstat -m 0
true	Use criteria
0.0	Minimum peptide probability
0.05	Peptide global false discovery rate
0.0	Minimum protein probability
1.0	Protein false discovery rate
1	Minimum charge state
16	Maximum charge state
0.0	Minimum ion proportion
1000	Maximum Sp rank
-1.0	Minimum Sp score
Require	Modified peptide inclusion
Any	Tryptic status requirement
false	Multiple, ambiguous IDs allowed
Ignore	Peptide validation handling
XCorr	Purge duplicate peptides by protein
false	Include only loci with unique peptide
true	Remove subset proteins
Ignore	Locus validation handling
0	Minimum modified peptides per locus
2	Minimum peptides per locus

Locus	Sequence Count	Spectrum Count	Sequence Coverage	Length	MolWt	pI	Validation Status	Descriptive Name
Unique	FileName	XCorr	DeltCN	Conf%	M+H+	CalcM+H+	TotalIntensity	SpR	ZScore	IonProportion	Redundancy	Sequence
sp|Q9Y2J8|PADI2_HUMAN	52	149	56.1%	665	75564	5.6	U	Protein-arginine deiminase type-2 OS=Homo sapiens GN=PADI2 PE=1 SV=2 
*	20190912_Thompson_PAD2_trypsin_t3_01.21283.21283.4	3.5436	0.2896	100.0	4183.1655	4182.1553	5999.9	2	5.078	17.1	1	R.TVR*LQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLK.H
*	20190912_Thompson_PAD2_trypsin_t3_01.10221.10221.3	6.1728	0.512	100.0	2578.214	2578.2173	7705.0	1	8.407	35.2	28	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t3_01.12441.12441.4	5.7628	0.413	100.0	2578.213	2578.2173	7238.0	1	7.129	28.8	64	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t3_01.10194.10194.5	3.3509	0.1811	100.0	2579.2178	2578.2173	9924.4	8	4.796	23.3	1	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t3_01.09818.09818.4	4.8917	0.3369	100.0	2862.373	2862.377	5380.8	1	5.601	31.9	1	K.HSEHVWVEVVRDGEAEEVATNGKQR*.W
*	20190912_Thompson_PAD2_trypsin_t3_01.09809.09809.5	4.2435	0.3191	100.0	2862.3774	2862.377	9345.4	1	5.689	24.5	1	K.HSEHVWVEVVRDGEAEEVATNGKQR*.W
*	20190912_Thompson_PAD2_trypsin_t3_01.10005.10005.5	2.1559	0.1073	96.3	2863.385	2863.361	5024.2	3	3.363	26.6	1	K.HSEHVWVEVVR*DGEAEEVATNGKQR*.W
*	20190912_Thompson_PAD2_trypsin_t3_01.13893.13893.2	2.5614	0.1464	97.6	1458.8041	1458.8069	7643.9	1	4.744	72.7	1	K.QR*WLLSPSTTLR.V
*	20190912_Thompson_PAD2_trypsin_t3_01.13907.13907.3	2.8606	0.2392	100.0	1459.809	1458.8069	7149.4	3	5.003	45.5	1	K.QR*WLLSPSTTLR.V
*	20190912_Thompson_PAD2_trypsin_t3_01.17402.17402.3	3.136	0.3491	100.0	2882.4143	2881.4365	9125.5	11	6.285	23.0	1	K.QR*WLLSPSTTLRVTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.13601.13601.4	3.1082	0.4332	100.0	2882.4565	2881.4365	7007.8	13	6.152	16.7	1	K.QRWLLSPSTTLR*VTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.17205.17205.3	4.3708	0.2195	100.0	2882.4194	2882.4207	9624.5	1	5.891	29.0	2	K.QR*WLLSPSTTLR*VTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.15440.15440.3	3.6902	0.1642	100.0	2359.1526	2359.1504	8359.9	14	3.994	32.5	1	K.KASWTWGPEGQGAILLVNCDR*.E
*	20190912_Thompson_PAD2_trypsin_t3_01.16540.16540.3	5.1277	0.412	100.0	3211.621	3210.6045	7125.7	3	6.663	25.0	2	K.KASWTWGPEGQGAILLVNCDR*ETPWLPK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.17725.17725.4	4.332	0.2777	100.0	3210.6018	3210.6045	7321.3	2	5.411	21.6	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.15470.15470.4	4.1108	0.3711	100.0	4143.9707	4142.97	6877.2	1	6.117	21.6	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPKEDCRDEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.16130.16130.4	3.8313	0.1725	100.0	4145.953	4142.97	10429.1	1	4.533	18.6	1	K.KASWTWGPEGQGAILLVNCDRETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.14977.14977.5	3.347	0.1861	100.0	4142.9834	4142.97	6139.1	30	4.245	13.6	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPKEDCRDEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.15569.15569.5	3.8264	0.2471	100.0	4143.971	4143.9546	5080.7	23	5.093	16.2	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.17051.17051.3	3.8478	0.2885	100.0	2231.0571	2231.0554	6515.2	2	5.021	35.5	1	K.ASWTWGPEGQGAILLVNCDR*.E
*	20190912_Thompson_PAD2_trypsin_t3_01.18358.18358.3	2.5017	0.2278	100.0	3082.508	3082.5095	4621.2	26	5.236	17.3	1	K.ASWTWGPEGQGAILLVNCDR*ETPWLPK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.15777.15777.5	6.5758	0.3992	100.0	4015.895	4014.8755	8311.5	2	5.63	15.9	1	K.ASWTWGPEGQGAILLVNCDR*ETPWLPKEDCRDEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.08876.08876.3	2.7667	0.1666	100.0	1803.8197	1803.8223	8887.5	1	3.718	34.6	1	R.ETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.13738.13738.2	2.6978	0.3415	97.6	1708.8589	1708.8613	8729.5	1	5.738	61.5	1	K.EDLKDMSQMILR*TK.G
*	20190912_Thompson_PAD2_trypsin_t3_01.13728.13728.3	2.6108	0.2497	100.0	1708.8608	1708.8613	9169.2	144	4.602	36.5	1	K.EDLKDMSQMILR*TK.G
*	20190912_Thompson_PAD2_trypsin_t3_01.20870.20870.4	4.0936	0.2731	100.0	4297.151	4296.133	6625.6	4	3.082	18.9	1	R.TKGPDR*LPAGYEIVLYISMSDSDKVGVFYVENPFFGQR.Y
*	20190912_Thompson_PAD2_trypsin_t3_01.20655.20655.5	3.422	0.2316	100.0	4297.1494	4296.133	7517.8	73	4.487	15.2	3	R.TKGPDR*LPAGYEIVLYISMSDSDKVGVFYVENPFFGQR.Y
*	20190912_Thompson_PAD2_trypsin_t3_01.10563.10563.3	2.2058	0.1244	98.3	1428.6683	1428.6694	7104.0	44	3.677	42.5	1	K.VCFQYLNR*GDR.W
*	20190912_Thompson_PAD2_trypsin_t3_01.10665.10665.2	2.2958	0.15	97.7	1429.6519	1429.6534	8233.8	3	4.16	65.0	1	K.VCFQYLNR*GDR*.W
*	20190912_Thompson_PAD2_trypsin_t3_01.19149.19149.3	4.1575	0.3863	100.0	3385.5923	3384.611	9627.2	1	6.136	23.1	1	K.VCFQYLNR*GDRWIQDEIEFGYIEAPHK.G
*	20190912_Thompson_PAD2_trypsin_t3_01.18016.18016.4	4.5946	0.3788	100.0	3384.6082	3384.611	9565.6	1	5.697	25.6	1	K.VCFQYLNR*GDRWIQDEIEFGYIEAPHK.G
*	20190912_Thompson_PAD2_trypsin_t3_01.18777.18777.5	5.3625	0.0457	96.1	4455.192	4452.1875	7551.8	4	5.261	19.8	1	K.VCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPR*.D
*	20190912_Thompson_PAD2_trypsin_t3_01.19213.19213.5	3.6046	0.0994	97.4	4453.195	4452.1875	8183.8	1	4.364	16.3	1	K.VCFQYLNR*GDRWIQDEIEFGYIEAPHKGFPVVLDSPR.D
*	20190912_Thompson_PAD2_trypsin_t3_01.16144.16144.5	2.7433	0.2292	100.0	3372.6843	3371.67	9173.8	316	4.33	20.5	1	R.GDR*WIQDEIEFGYIEAPHKGFPVVLDSPR.D
*	20190912_Thompson_PAD2_trypsin_t3_01.16561.16561.3	2.8468	0.3108	100.0	3043.5347	3043.5205	7476.0	17	5.325	18.0	1	R.WIQDEIEFGYIEAPHKGFPVVLDSPR*.D
*	20190912_Thompson_PAD2_trypsin_t3_01.12873.12873.2	1.7508	0.3377	98.6	1614.8468	1614.8491	6566.6	184	5.274	35.7	1	K.GFPVVLDSPR*DGNLK.D
*	20190912_Thompson_PAD2_trypsin_t3_01.14329.14329.2	1.8952	0.2896	98.9	2201.1575	2201.1606	7732.1	25	4.457	26.3	1	K.GFPVVLDSPR*DGNLKDFPVK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.14407.14407.3	4.3325	0.3181	100.0	2201.159	2201.1606	9768.1	2	6.55	32.9	1	K.GFPVVLDSPR*DGNLKDFPVK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.18637.18637.4	4.4245	0.2951	100.0	3548.8408	3548.843	6372.9	1	5.61	24.2	1	K.GFPVVLDSPR*DGNLKDFPVKELLGPDFGYVTR.E
*	20190912_Thompson_PAD2_trypsin_t3_01.22030.22030.4	2.2158	0.2074	100.0	4212.108	4211.1074	4850.0	46	4.277	14.5	1	K.ELLGPDFGYVTR*EPLFESVTSLDSFGNLEVSPPVTVNGK.T
*	20190912_Thompson_PAD2_trypsin_t3_01.19553.19553.5	4.3653	0.107	99.0	4991.6216	4991.6157	5448.8	2	3.663	12.2	1	R.EPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGR*R.M
*	20190912_Thompson_PAD2_trypsin_t3_01.18304.18304.3	2.8976	0.115	98.0	2510.3418	2510.344	11077.4	1	3.77	29.5	1	K.TYPLGR*ILIGSSFPLSGGR*R*MTK.V
*	20190912_Thompson_PAD2_trypsin_t3_01.13499.13499.2	2.5555	0.3346	97.9	1460.8209	1460.8225	5949.1	1	5.258	46.2	1	R.ILIGSSFPLSGGR*R.M
*	20190912_Thompson_PAD2_trypsin_t3_01.09711.09711.2	1.9589	0.203	98.2	877.5142	877.5147	5910.4	26	4.185	75.0	1	K.VVR*DFLK.A
*	20190912_Thompson_PAD2_trypsin_t3_01.13881.13881.2	4.0336	0.2045	98.8	1955.9934	1953.9922	8591.2	1	4.506	63.3	2	K.ILSNESLVQENLYFQR*.C
*	20190912_Thompson_PAD2_trypsin_t3_01.10673.10673.4	2.8994	0.1302	99.6	1461.7501	1461.7524	8745.1	3	3.529	46.7	1	R.CLDWNR*DILKK.E
*	20190912_Thompson_PAD2_trypsin_t3_01.19120.19120.3	3.3893	0.3038	100.0	2651.2268	2651.242	7276.8	2	4.809	33.3	2	K.MDEDHR*AR*AFFPNMVNMIVLDK.D
*	20190912_Thompson_PAD2_trypsin_t3_01.19499.19499.4	4.9406	0.3606	100.0	4362.108	4361.094	6868.8	1	5.976	20.4	1	R.AFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t3_01.19454.19454.5	8.4711	0.4094	100.0	4362.1167	4361.094	9660.8	1	7.157	18.8	1	R.AFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t3_01.13860.13860.4	4.9318	0.4254	100.0	2741.29	2741.2737	7419.7	1	7.449	26.5	1	K.DLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t3_01.07197.07197.2	2.1174	0.2359	99.0	1545.7576	1545.7596	5768.2	29	4.932	37.5	1	K.FLGEVHCGTNVR*R.K
*	20190912_Thompson_PAD2_trypsin_t3_01.07304.07304.3	2.5966	0.2722	100.0	1545.7606	1545.7596	7439.1	94	4.861	35.4	2	K.FLGEVHCGTNVR*R.K
sp|Q9ULC6|PADI1_HUMAN	2	2	4.4%	663	74666	6.5	U	Protein-arginine deiminase type-1 OS=Homo sapiens GN=PADI1 PE=1 SV=2 
*	20190912_Thompson_PAD2_trypsin_t3_01.13747.13747.2	1.9274	0.3715	98.0	1888.922	1888.9227	4930.1	2	6.031	28.1	1	R.VSGSSGVEVFMVYNR*TR.V
	20190912_Thompson_PAD2_trypsin_t3_01.17339.17339.2	2.1476	0.2818	98.8	1394.6953	1394.7432	3517.0	1	5.002	50.0	1	K.R*ILGPDFGYVTR.E
	Proteins	Peptide IDs	Spectra
Unfiltered	15558	22860	35853
Filtered	2	54	151
Forward matches	2	54	151
Decoy matches	0	0	0
Forward FP rate	0.0	0.0	0.0

Classification	Nonredundant Proteins	Redundant Proteins
Unclassified	0	0
